金春股份 reported revenue of ¥0.64B for the period ended 2026-06-30, +20.3% year on year. Net income was ¥0.03B, a 5.3% net margin on a 13.3% gross margin. The largest revenue line is 非织造布 at 73% of the total. Free cash flow for the period was ¥0.16B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.64B | +20.3% |
| Gross profit | ¥0.09B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.03B | +96.6% |
| Gross margin | 13.3% | Net margin 5.3% |
| Revenue Q/Q | +15.5% | — |
| Segment | Revenue | Share |
|---|---|---|
| 非织造布 | ¥0.47B | 73.0% |
| ES纤维 | ¥0.13B | 20.2% |
| 纺织制成品 | ¥0.03B | 3.9% |
| 其他业务 | ¥0.01B | 1.8% |
| 非织造布材料制品 | ¥0.01B | 1.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.56B | 86.7% |
| R&D | ¥0.02B | 3.7% |
| SG&A | ¥0.02B | 3.2% |
| Tax & other | ¥0.00B | 0.6% |
| Item | Amount |
|---|---|
| Total assets | ¥1.95B |
| Total liabilities | ¥0.27B |
| Shareholders' equity | ¥1.68B |
| Equity / assets | 86.1% |
| Operating cash flow | ¥0.16B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.16B |
| Cash conversion (OCF / net income) | 79% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
维康药业 ・ 大叶股份 ・ 迦南智能 ・ 盛德鑫泰 ・ 万胜智能 ・ 龙利得 ・ 狄耐克 ・ 海昌新材 ・ 华业香料 ・ 谱尼测试 ・ 稳健医疗 ・ 爱克股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies